Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Drospirenone and VTE (CROSBI ID 159228)

Prilog u časopisu | Pismo uredniku

Leppée, Marcel ; Erić, Mirela ; Čulig, Josip Drospirenone and VTE // Journal of family planning and reproductive health care, 36 (2010), 1; 44-44. doi: 10.1783/147118910790291127

Podaci o odgovornosti

Leppée, Marcel ; Erić, Mirela ; Čulig, Josip

engleski

Drospirenone and VTE

The number of reported side effects of all drugs of any kind increased by 69.2%, i.e. from 993 in 2005 to 1680 in 2008. Annual trends in the rate of hospitalization showed a decline in women of all age groups as well as in those at a potential exposure to oral contraceptives. Data on the significant increase in the utilization of DRSP/EE and concurrently very low rates of hospitalization for venous thromboembolism, which continue to decline, suggest that there is no correlation between these two parameters.

drospirenone; venous thromboembolism

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

36 (1)

2010.

44-44

objavljeno

1471-1893

10.1783/147118910790291127

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Biologija

Poveznice
Indeksiranost